These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19794350)

  • 1. Clinical trial going on for 10 years - how is it possible?
    Mimica N; Folnegović-Smalc V; Uzun S; Kozumplik O
    Psychiatr Danub; 2009 Sep; 21(3):329. PubMed ID: 19794350
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of antipsychotic agents in the management of behavioral disorders in the elderly with dementia: evaluating recent clinical data.
    Worz CR
    Director; 2008; 16(2):17-20. PubMed ID: 19343879
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of psychotic disorders in the elderly.
    Kirkwood CK
    Director; 2003; 11(4):160, 163-5. PubMed ID: 14608700
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should the second generation antipsychotic agents be used as drugs of choice?].
    Rimón R; Leinonen E
    Duodecim; 2002; 118(6):585-90. PubMed ID: 12233002
    [No Abstract]   [Full Text] [Related]  

  • 5. "Noncomplainers" or "noncompliers".
    Barkin RL; Stein ZL
    J Clin Psychiatry; 1988 Jan; 49(1):38. PubMed ID: 2891690
    [No Abstract]   [Full Text] [Related]  

  • 6. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376
    [No Abstract]   [Full Text] [Related]  

  • 7. Using outreach and support to improve medication compliance.
    McGirr K
    Behav Healthc Tomorrow; 2002 Dec; 11(6):15-21. PubMed ID: 12506599
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the psychiatrist in improving patient compliance.
    Hotujac L
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():27-33. PubMed ID: 17262009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.
    Angst J; Bech P; Bobon D; Engel R; Hippius H; Janzen GJ; Lecrubier Y; Lingjaerde O; Möller HJ; Montgomery S
    Pharmacopsychiatry; 1991 Sep; 24(5):149-52. PubMed ID: 1685571
    [No Abstract]   [Full Text] [Related]  

  • 10. Addressing the limitations of the CATIE study.
    Kasper S; Winkler D
    World J Biol Psychiatry; 2006; 7(2):126-7. PubMed ID: 16684687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of cyamemazine].
    Nurowska K
    Psychiatr Pol; 1983; 17(5-6):389-95. PubMed ID: 6142492
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges in the management of psychotic symptoms in long-term care.
    Gravenstein S; Beier M; Singer C
    J Am Med Dir Assoc; 2003; 4(4 Suppl):H17-20. PubMed ID: 12857363
    [No Abstract]   [Full Text] [Related]  

  • 14. How long should treatments be continued?
    Craig JC; Webster AC; Loy C
    BMJ; 2010 Aug; 341():c4102. PubMed ID: 20724403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controversy regarding psychosis therapy].
    Echarri Arrieta E
    Farm Hosp; 2004; 28(3):149-53. PubMed ID: 15222868
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug development update.
    Buckley PF
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):170. PubMed ID: 25604332
    [No Abstract]   [Full Text] [Related]  

  • 17. Is it acceptable for people to be paid to adhere to medication? No.
    Shaw J
    BMJ; 2007 Aug; 335(7613):233. PubMed ID: 17673765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it acceptable for people to be paid to adhere to medication? Yes.
    Burns T
    BMJ; 2007 Aug; 335(7613):232. PubMed ID: 17673764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of psychosis in primary care.
    Kuruvilla A; Jacob KS
    Natl Med J India; 2006; 19(6):325-9. PubMed ID: 17343018
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of antipsychotic medication-time to rethink trial design.
    Speyer H; Begemann M; Albert N; Weller A; Nordentoft M; Veling W; Sommer IE; Allott K; Killackey E
    Lancet Psychiatry; 2020 Oct; 7(10):841-842. PubMed ID: 32949515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.